IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus

NCT01841619 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Lupus Erythematosus

Interventions

DRUG: IVIg

Sponsor

University of California, Irvine

Collaborators

[object Object]